1-3 of 3
Martha Wadleigh, M.D.
Close
Sort by
Journal Articles

Clinical Outcomes of Acute Promyelocytic Leukemia (APL) Patients According to FLT3 Mutation Status

Harshabad Singh, MBBS, Lillian Werner, Daniel J DeAngelo, MD, PhD, Philip C. Amrein, MD, Martha Wadleigh, M.D., Karen K Ballen, MD, Edward Fox, Ilene Galinsky, ANP, Donna Neuberg, ScD, Richard M Stone, M.D., Eyal C Attar, MD
Journal: Blood
Blood (2010) 116 (21): 2689.
https://doi.org/10.1182/blood.V116.21.2689.2689
Published: 2010
Journal Articles

Comparison of High Dose Chemotherapy with Autologous Stem Cell Rescue (ASCT) Versus Consolidation Chemotherapy for Patients < 60 with Cytogenetically Normal AML (CN-AML) and Flt3 ITD

Harshabad Singh, MBBS, Lillian Werner, Daniel J DeAngelo, MD, PhD, Philip C. Amrein, MD, Martha Wadleigh, M.D., Karen K Ballen, MD, Ilene Galinsky, ANP, Donna Neuberg, ScD, Edward Fox, Richard M Stone, M.D., Eyal C Attar, MD
Journal: Blood
Blood (2010) 116 (21): 3555.
https://doi.org/10.1182/blood.V116.21.3555.3555
Published: 2010
Journal Articles

PKC412 Inhibits the ZNF198-FGFR1 Fusion Tyrosine Kinase and Is Efficacious in Treatment of t(8;13)(p11;q12) Associated Stem Cell Myeloproliferative Disease.

Jing Chen, Ph.D., Daniel J. DeAngelo, M.D., Jeffery L. Kutok, M.D., Ph.D., Ifor R. Williams, M.D., Ph.D., Benjamin H. Lee, M.D., Ph.D., Martha Wadleigh, M.D., Nicole Duclos, Sarah Cohen, Jennifer Adelsperger, Rachel Okabe, Allison Coburn, Ilene Galinsky, Brian J.P. Huntly, M.D., Ph.D., Pamela Cohen, Ph.D., Thomas Meyer, Ph.D., Doriano Fabbro, Ph.D., Lolita Banerji, Ph.D., James D. Griffin, M.D., Sheng Xiao, M.D., Jonathan A. Fletcher, M.D., Richard M. Stone, M.D., D. Gary Gilliland, M.D., Ph.D.
Journal: Blood
Blood (2004) 104 (11): 2549.
https://doi.org/10.1182/blood.V104.11.2549.2549
Published: 2004